Serum IL-6 level at the onset of IgG4-RD may be significantly correlated with clinical inflammatory parameters and it may also be associated with involvement of the bile duct, liver, and spleen. This evidence concerns the gene IL6 and immunoglobulin G4-related sclerosing disease.